Jing Zhang

发表

Inhibition of arginase by CB-1158 blocks myeloid cell-mediated immune suppression in the tumor microenvironment

Weiqun Li, Melissa G. Works, P. Murray, 2017, Journal of Immunotherapy for Cancer.

The Axl receptor tyrosine kinase is an adverse prognostic factor and a therapeutic target in esophageal adenocarcinoma

E. Montgomery, G. Riggins, J. Eshleman, 2010, Cancer biology & therapy.

Discovery of a Series of Potent, Selective, and Orally Bioavailable Nucleoside Inhibitors of CD73 That Demonstrates In Vivo Antitumor Activity.

Clarissa C. Lee, Weiqun Li, M. V. Van Zandt, 2022, Journal of medicinal chemistry.

R428, a selective small molecule inhibitor of Axl kinase, blocks tumor spread and prolongs survival in models of metastatic breast cancer.

Y. Hitoshi, D. Payan, Weiqun Li, 2010, Cancer research.

R 428 , a Selective Small Molecule Inhibitor of Axl Kinase , Blocks Tumor Spread and Prolongs Survival in Models of Metastatic Breast Cancer

Y. Hitoshi, D. Payan, Weiqun Li, 2010 .

Discovery of dual Axl/VEGF-R2 inhibitors as potential anti-angiogenic and anti-metastatic drugs for cancer chemotherapy.

Weiqun Li, D. Goff, Raj K. Singh, 2017, Bioorganic & medicinal chemistry letters.

Selective Small Molecule Inhibitor of Axl Kinase , Blocks Tumor Spread and Prolongs Survival in Models of Metastatic Breast Cancer

Y. Hitoshi, D. Payan, Weiqun Li, 2010 .

CB-839, a selective glutaminase inhibitor, has anti-tumor activity in renal cell carcinoma and synergizes with everolimus and receptor tyrosine kinase inhibitors

Weiqun Li, M. Bennett, F. Parlati, 2016 .

Abstract 4134: Reversal of adenosine-mediated immune suppression by CB-708, an orally bioavailable and potent small molecule inhibitor of CD73

Clarissa C. Lee, Weiqun Li, F. Parlati, 2019, Immunology.